911052-85-2 Usage
Uses
Used in Pharmaceutical Industry:
(5-Bromothiazol-2-yl)methanol could be used as an intermediate in the synthesis of pharmaceutical compounds for [specific medical condition or treatment] due to its potential reactivity and structural features.
Used in Chemical Synthesis:
In the chemical industry, (5-Bromothiazol-2-yl)methanol might serve as a building block or reactant in the production of various organic compounds, leveraging its reactivity and functional groups.
Used in Research and Development:
As a novel compound, (5-Bromothiazol-2-yl)methanol could be utilized in research settings to explore its chemical properties, potential reactions, and possible applications in different fields, such as materials science or medicinal chemistry.
[Please replace the placeholders with specific applications and reasons as they become available from reliable sources or further research.]
Check Digit Verification of cas no
The CAS Registry Mumber 911052-85-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,1,0,5 and 2 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 911052-85:
(8*9)+(7*1)+(6*1)+(5*0)+(4*5)+(3*2)+(2*8)+(1*5)=132
132 % 10 = 2
So 911052-85-2 is a valid CAS Registry Number.
911052-85-2Relevant academic research and scientific papers
NOVEL BICYCLIC NITROGEN CONTAINING HETEROARYL TGR5 RECEPTOR MODULATORS
-
Page/Page column 136, (2012/11/13)
Novel compounds of Formula I:or an enantiomer, diastereomer, tautomer, prodrug or salt thereof, wherein m, Q, T, U, V, ring A, X, Y, R3, R4, R4a, R5a, R5b, R5c, R5d, R5e, R6a, R6b, and R6c are defined herein, are provided which are TGR5 G protein-coupled receptor modulators. TGR5 G protein-coupled receptor modulators are useful in treating, preventing, or slowing the progression of diseases requiring TGR5 G protein-coupled receptor modulator therapy. Thus, the disclosure also concerns compositions comprising these novel compounds and methods of treating diseases or conditions related to the activity of the TGR5 G protein-coupled receptor by using any of these novel compounds or a composition comprising any of such novel compounds.
